Skip to main content
Table of Contents
Print

What Clinical Trials Have Been Conducted on Cannabis for CRPS? 

Author: Dr. Clarissa Morton, PharmD

With interest in cannabis-based therapies growing, many CRPS patients are wondering whether the research backs up the buzz. While large-scale studies remain limited, a number of CRPS cannabis clinical trials have explored its potential, providing early insights into safety, dosing, and effectiveness. 

These studies are helping shape future treatment protocols, though they also come with some notable challenges and gaps. 

What the Research Says So Far 

Here’s what we know about CRPS cannabis clinical trials to date: 

  • Early evidence of pain relief 
    Several small-scale trials have shown that cannabis, particularly formulations containing both THC and CBD, can help reduce neuropathic pain and improve sleep in CRPS patients. However, many of these studies are limited in size, duration, and scope, making it difficult to draw definitive conclusions. 
  • Study limitations to consider 
    Despite encouraging results, most trials face common study limitations, including small participant groups, short follow-up periods, and inconsistent dosing protocols. These factors make it challenging to fully assess long-term effects or identify which patients benefit the most. 
  • Biomarker analysis on the rise 
    Some newer trials are beginning to incorporate biomarker analysis to track how cannabis affects inflammation and nerve sensitivity on a biological level. This could lead to more personalised treatment options in the future. 
  • Mixed trial outcomes 
    Not all research has been positive. Some trials report only modest pain relief or inconsistent results between participants. This highlights the complexity of CRPS and the need for more robust, well-controlled studies before cannabis becomes a first-line treatment. 

While the field of CRPS cannabis clinical trials is still developing, early findings suggest promise, particularly when cannabis is used as part of a broader, individualised treatment plan. 

Visit providers like LeafEase to explore evidence-based cannabis therapies alongside expert medical support. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Complex Regional Pain Syndrome (CRPS).

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories